FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 38 filers reported holding FUSION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,339,800 | -44.3% | 2,823,000 | 0.0% | 0.16% | -42.3% |
| Q2 2023 | $13,183,410 | +23.9% | 2,823,000 | 0.0% | 0.28% | +18.6% |
| Q1 2023 | $10,642,710 | +457.8% | 2,823,000 | +1638.5% | 0.24% | +523.7% |
| Q4 2020 | $1,908,000 | -83.7% | 162,378 | -83.3% | 0.04% | -86.6% |
| Q3 2020 | $11,684,000 | -46.8% | 972,046 | -22.7% | 0.28% | -55.6% |
| Q2 2020 | $21,960,000 | – | 1,257,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $11,562 | 3.36% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $9,285,598 | 3.10% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4,917,100 | 2.14% |
| Sio Capital Management, LLC | 260,448 | $820,411 | 0.30% |
| BRAIDWELL LP | 2,000,000 | $6,300,000 | 0.21% |
| Orbimed Advisors | 3,224,770 | $10,158,026 | 0.19% |
| TPG GP A, LLC | 2,551,794 | $8,038,151 | 0.16% |
| Artal Group S.A. | 750,000 | $2,363 | 0.13% |
| RA Capital Management | 659,992 | $2,078,975 | 0.04% |
| SECTORAL ASSET MANAGEMENT INC | 57,297 | $180,486 | 0.04% |